Who Attends?

The Neoantigen Summit brings together the pioneers weaponizing neoantigen immunotherapy and vaccine development to share key clinical data and insights from sample acquisition, all the way through to vaccine manufacturing and getting a product to market.

Receive up to date read outs on current clinical programs; regulations for individualized products and N of 1 trials; and scaling out manufacture for personalized therapeutics.

Who Will You Meet?

As the only dedicated event to focus exclusively on neoantigen-based therapeutic development, our audience comprises of over 60% decision-makers; VPs, Directors and C-Level Executives. Drug developers and academic institutions make up over 80% of the room. So at the Neoantigen Summit you’re sure to meet the leading minds in this rapidly advancing space.


“A great opportunity to meet some of the brightest minds and leading entrepreneurs in the industry. A key event for anyone intending to translate microbiome science into impactful products for patients.”

Chr. Hansen

"The Microbiome Movement has proven to deliver a superior conference where scientific content is consistently emphasized concurrently with  relationship building opportunities. An excellent platform for advancement of the microbiome industry."


"It's one of the best conferences targeting the microbiome area. Over the last two years, the program has grown really nicely to address many of the different hurdles and opportunities that we're facing in the microbiome area."


“This meeting is possibly the best in the microbiome field for a biotech company, for networking and hearing the latest developments.”